Novo Nordisk (NVO) submitted regulatory application for semaglutide in both the U.S. and the EU for the treatment of adults with type II diabetes.
- Zacks•2 days ago
Pfizer Inc. (PFE) announced new positive data from a randomized phase II study on its investigational candidate glasdegib (PF-04449913) for the first-line treatment of patients with acute myeloid leukemia (AML).
- Zacks•5 days ago
bluebird bio (BLUE) reported encouraging interim phase I data on its anti-BCMA CAR T cell candidate, bb2121, in relapsed/refractory multiple myeloma patients.
VNDA : Summary for Vanda Pharmaceuticals Inc. - Yahoo Finance
Vanda Pharmaceuticals Inc. (VNDA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||15.25 x 100|
|Ask||15.30 x 1200|
|Day's Range||15.05 - 16.00|
|52 Week Range||6.91 - 18.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-20.21|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|